Similar to how CTLA-4 polymorphism predisposes an individual to IBD, it is possible that a similar relationship exists between CTLA-4 and pancreatitis in humans that is exacerbated in ICI therapy, resulting in AIP-3. The gene discussed is CTLA4; the disease is inflammatory bowel disease.